Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne

Archives of Dermatology

Volumn 139, Issue 4, 2003, Pages 459-464

  Skidmore, Robert ^a,h   Kovach, Rodney ^c   Walker, Clay ^b   Thomas, John ^d   Bradshaw, Mark ^e   Leyden, James ^f   Powala, Christopher ^g   Ashley, Robert ^g  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e 206 Carnegie Center   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g NONE   (United States)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; PLACEBO;

ACNE; ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HEARTBURN; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MICROFLORA; MYCOSIS; OPPORTUNISTIC INFECTION; PHOTOTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN FLORA; STOMACH PAIN; VAGINITIS;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; HUMANS; MALE; SKIN;

EID: 0037388301     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.4.459     Document Type: Article

References (23)

1. Meynadier J, Alirezai M. Systemic antibiotics for acne. Dermatology. 1998;196:135-139.
2. Vibramycin [package insert]. New York, NY: Pfizer Inc; 1993.
3. Greenward RA, Golub LM. Preface: nonantibiotic properties of tetracycrines. Adv Dent Res. 1998;12:1.
4. Leyden J, Levy S. The development of antibiotic resistance in Propionibacterium acnes. Cutis. 2001;67:21-24.
5. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline: a dose-related phenomenon. Clin Exp Dermatol. 1993;18:425-427.
6. Golub LM, Lee HM, Lehrer G, et al. Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodontal Res. 1983;18:516-526.
7. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A nonantibacterial chemically modified tetracycline inhibits mammalian collagenase activity. J Dent Res. 1987;66:1310-1314.
8. Golub LM, Lee H-M, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple nonantimicrobial mechanisms. Adv Dent Res. 1998;12:12-26.
9. Schroeder K, Lee H, Wolff M, Ramamurthy N, Golub L. Low-dose tetracyclines (TCs) decrease elastase and β-glucuronidase activities in gingival crevicular fluid (GCF) [abstract 1090]. J Dent Res. 1990;69(special issue):245.
10. Schroeder KL, Ramamurthy NS, Szczepanek KA, et al. Low-dose doxycycline prevents attachment loss in adult periodontitis [abstract 1936]. J Dent Res. 1992;71:758.
11. Periostat [package insert]. Newtown, Pa: CollaGenex Pharmaceuticals Inc; 2001.
12. Vibramycin Summary Basis of Approval. Washington, DC: Food and Drug Administration Freedom of Information Office; 1967.
13. Walker C, Nango S, Lennon J, et al. Effect of Subantimicrobial Dose Doxycycline (SDD) on Intestinal and Vaginal Flora. Alexandria, Va: International Association of Dental Research; 2000.
14. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res. 1990;25:321-330.
15. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997;46:310-319.
16. Shalita AR, Lee W-L. Inflammatory acne. Dermatol Clin. 1983;1:361-364.
17. Webster GF, McGinley KJ, Leyden JJ. Inhibition of lipase production in Propionibacterium acnes by subminimal-inhibitory concentrations of tetracycline and erythromycin. Br J Dermatol. 1981;104:453-457.
18. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. Antimicrob Agents Chemother. 1982;21:770-772.
19. Speer BS, Shoemaker NB, Salyers AA. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev. 1992;5:387-399.
20. Caton JG. Evaluation of Periostat for patient management. Compend Contin Educ Dent. 1999;20:451-462.
21. Eklund KK, Sorsa T. Tetracycline derivative CMT-3 inhibits cytokine production, degranulation, and proliferation in cultured mouse and human mast cells. Ann N Y Acad Sci. 1999;878:689-691.
22. Kirkwood KL, Golub LM, Bradford PG. Nonantimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts. Ann N Y Acad Sci. 1999;878:667-670.
23. Toyoda M, Morohashi M. Pathogenesis of acne. Med Electron Microsc. 2001;34:29-40.